Three-Year Outcome after Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease

Circulation

Volumn 109, Issue 9, 2004, Pages 1114-1120

  Legrand, Victor M G ^a   Serruys, Patrick W ^b   Unger, Felix ^d   Van Hout, Ben A ^e   Vrolix, Mathias C M ^f   Fransen, Geert M P ^f   Nielsen, Torsten Toftegaard ^g   Paulsen, Peter Kildeberg ^g   Gomes, Ricardo Seabra ^h   De Queiroz E Melo, João M G ^h   Marques Dos Santos Neves, José P ^h   Lindeboom, Wietze ^c   Backx, Bianca ^c  

^a CHU SART TILMAN   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CARDIALYSIS   (Netherlands)

^d University Klinik für Herzchirurgie   (Austria)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f DEPARTMENT OF CARDIOLOGY   (Belgium)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h Hospital de la Santa Cruz   (Portugal)

Author keywords

Coronary disease; Cost benefit analysis; Revascularization; Stents; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; CORONARY STENT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STENT; SURVIVAL RATE; TREATMENT OUTCOME;

CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; COST-BENEFIT ANALYSIS; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 12144289144     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000118504.61212.4B     Document Type: Article

References (27)

1. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 1001;344:1117-1124.
2. BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol. 2000;35:1122-1129.
3. Bourassa MG, Kip KE, Jacobs AK, et al. Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in non diabetic patients who are candidates for coronary artery bypass graft surgery? J Am Coll Cardiol. 1999;33:1627-1636.
4. Bourassa MG, Enjalbert M, Campeau L, et al. Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later. Am J Cardiol. 1984;53:102C-107C.
5. Serruys PW, Unger F, Van Hout BA, et al. The ARTS (Arterial Revascularization Therapies Study): background, goals and methods. Int J Cardiovasc Intervent. 1999;2:41-50.
6. Dolan P. Modelling valuations for Euro Qol health states. Med Care. 1997;35:1095-1108.
7. Serruys PW, Van Hout B, Bonnier H, et al. Randomized comparison of implantation of heparin coated stents with balloon angioplasty in selected patients with coronary artery disease. Lancet. 1998;352:673-681.
8. Greenland S, Robins JM. Estimation of a common effect parameter from sparse follow-up data. Biometrics. 1985;41:55-68.
9. Kendal DG. Rank Correlation Methods. 3rd ed. London, UK: Charles Griffin; 1962.
10. Cox DR. Fieller's theorem and a generalization. Biometrika. 1967;54: 567-572.
11. Rodriguez A, Boullon F, Perez-Balino N, et al. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group. J Am Coll Cardiol. 1993;22: 1060-1067.
12. Hamm CW, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation. N Engl J Med. 1994;331:1037-1043.
13. CABRI Trial Participants. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation). Lancet. 1995;346: 1179-1184.
14. Henderson RA, Pocock SJ, Sharp SJ, et al. Long term results of RITA-1 trial: clinical cost comparisons of coronary angioplasty and coronary artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet. 1998;352:1419-1425.
15. King SB III, Kosinski AS, Guyton RA, et al. Eight-year mortality in the Emory Angioplasty versus Surgery Trial. J Am Coll Cardiol. 2000;35: 1116-1121.
16. Pocock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomised trial comparing coronary angioplasty with bypass surgery. Lancet. 1995;346:1184-1189.
17. Sim I, Gupta M, McDonald K, et al. A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery disease. Am J Cardiol. 1995;76:1025-1029.
18. Hlatky MA, Boothroyd DB, Brooks MM, et al. Clinical correlates of the initial and long-term cost of bypass surgery and coronary angioplasty. Am Heart J. 1999;138:376-383.
19. Abizaid A, Costa MA, Centemero M, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) Trial. Circulation. 2001;104:533-538.
20. Kornowski R, Mintz GS, Kent KM, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: a serial intravascular ultrasound study. Circulation. 1997;95: 1366-1369.
21. Pocock SJ, Henderson RA, Seed P, et al, for the RITA Trial Participants. Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery: 3-year follow-up in the Randomised Intervention Treatment of Angina (RITA) trial. Circulation. 1996;94: 135-142.
22. Währborg P, on behalf of the CABRI Trialists. Quality of life after coronary angioplasty or bypass surgery: 1-year follow-up in the Coronary Angioplasty versus Bypass Revascularization Investigation (CABRI) trial. Eur Heart J. 1999;20:653-658.
23. Hlatky MA, Rogers WJ, Johnstone I, et al, for the Bypass Angioplasty Revascularisation Investigation (BARI) Investigators. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med. 1997;336:92-99.
24. Serruys PW, de Bruyne B, Carlier S, et al. Randomized comparison of primary stenting and provisional balloon angioplasty guided: by flow velocity measurement. Doppler End Point Balloon Angioplasty, Trial Europe (DEBATE) II Study group. Circulation. 2000;102:2930-2937.
25. Suryapranata H, van't Hof AW, Hoorntje JC, et al. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation. 1998;97:2502-2505.
26. Cohen DJ, Taira DA, Berezin R, et al. Cost-effectiveness of coronary stenting in acute myocardial infarction: results from the Stent, Primary Angioplasty in Myocardial Infarction (stent-PAMI) trial. Circulation. 2001;104:3039-3045.
27. Stone GW, Grines CL, Rothbaum D, et al. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. J Am Coll Cardiol. 1997;29:901-907.